Literature DB >> 24982119

New mechanistic and therapeutic targets for pediatric heart failure: report from a National Heart, Lung, and Blood Institute working group.

Kristin M Burns1, Barry J Byrne2, Bruce D Gelb2, Bernhard Kühn2, Leslie A Leinwand2, Seema Mital2, Gail D Pearson2, Mark Rodefeld2, Joseph W Rossano2, Brian L Stauffer2, Michael D Taylor2, Jeffrey A Towbin2, Andrew N Redington2.   

Abstract

Entities:  

Keywords:  heart defects, congenital; heart failure; pediatrics

Mesh：

Substances：

Year:  2014        PMID： 24982119      PMCID： PMC4554711          DOI： 10.1161/CIRCULATIONAHA.113.007980

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  75 in total

1.  Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure.

Authors:  S Ghio; A Gavazzi; C Campana; C Inserra; C Klersy; R Sebastiani; E Arbustini; F Recusani; L Tavazzi
Journal:  J Am Coll Cardiol       Date:  2001-01       Impact factor: 24.094

Review 2.  MicroRNAs in cardiovascular therapeutics.

Authors:  Gerasimos Siasos; Dimitris Tousoulis; Panagiotis Tourikis; Savas Mazaris; Giorgos Zakynthinos; Evangelos Oikonomou; Eleni Kokkou; Christina Kollia; Christodoulos Stefanadis
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

3.  Synthesis of [18F]RGD-K5 by catalyzed [3 + 2] cycloaddition for imaging integrin αvβ3 expression in vivo.

Authors:  Leila Mirfeizi; Joe Walsh; Hartmuth Kolb; Lachlan Campbell-Verduyn; Rudi A Dierckx; Ben L Feringa; Philip H Elsinga; Tjibbe de Groot; Ivan Sannen; Guy Bormans; Sofie Celen
Journal:  Nucl Med Biol       Date:  2013-07       Impact factor: 2.408

4.  Meis1 regulates postnatal cardiomyocyte cell cycle arrest.

Authors:  Ahmed I Mahmoud; Fatih Kocabas; Shalini A Muralidhar; Wataru Kimura; Ahmed S Koura; Suwannee Thet; Enzo R Porrello; Hesham A Sadek
Journal:  Nature       Date:  2013-04-17       Impact factor: 49.962

5.  Human embryonic stem cells derived by somatic cell nuclear transfer.

Authors:  Masahito Tachibana; Paula Amato; Michelle Sparman; Nuria Marti Gutierrez; Rebecca Tippner-Hedges; Hong Ma; Eunju Kang; Alimujiang Fulati; Hyo-Sang Lee; Hathaitip Sritanaudomchai; Keith Masterson; Janine Larson; Deborah Eaton; Karen Sadler-Fredd; David Battaglia; David Lee; Diana Wu; Jeffrey Jensen; Phillip Patton; Sumita Gokhale; Richard L Stouffer; Don Wolf; Shoukhrat Mitalipov
Journal:  Cell       Date:  2013-05-15       Impact factor: 41.582

6.  Fetal reprogramming and senescence in hypoplastic left heart syndrome and in human pluripotent stem cells during cardiac differentiation.

Authors:  Naila Gaber; Mark Gagliardi; Pranali Patel; Caroline Kinnear; Cindy Zhang; David Chitayat; Patrick Shannon; Edgar Jaeggi; Uri Tabori; Gordon Keller; Seema Mital
Journal:  Am J Pathol       Date:  2013-07-17       Impact factor: 4.307

Review 7.  The role of miRNAs in regulating gene expression networks.

Authors:  Allan M Gurtan; Phillip A Sharp
Journal:  J Mol Biol       Date:  2013-03-13       Impact factor: 5.469

8.  Adverse biventricular remodeling in isolated right ventricular hypertension is mediated by increased transforming growth factor-β1 signaling and is abrogated by angiotensin receptor blockade.

Authors:  Mark K Friedberg; Mi-Young Cho; Jing Li; Renato S Assad; Mei Sun; Sagar Rohailla; Osami Honjo; Christian Apitz; Andrew N Redington
Journal:  Am J Respir Cell Mol Biol       Date:  2013-12       Impact factor: 6.914

9.  Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.

Authors:  Ping Liang; Feng Lan; Andrew S Lee; Tingyu Gong; Veronica Sanchez-Freire; Yongming Wang; Sebastian Diecke; Karim Sallam; Joshua W Knowles; Paul J Wang; Patricia K Nguyen; Donald M Bers; Robert C Robbins; Joseph C Wu
Journal:  Circulation       Date:  2013-03-21       Impact factor: 29.690

10.  Paranemin and the organization of desmin filament networks.

Authors:  S C Schweitzer; M W Klymkowsky; R M Bellin; R M Robson; Y Capetanaki; R M Evans
Journal:  J Cell Sci       Date:  2001-03       Impact factor: 5.285
View more
  14 in total

1.  A specified therapeutic window for neuregulin-1 to regenerate neonatal heart muscle.

Authors:  Federica Santoro; Makoto Sahara
Journal:  Ann Transl Med       Date:  2015-10

2.  Neuregulin stimulation of cardiomyocyte regeneration in mice and human myocardium reveals a therapeutic window.

Authors:  Brian D Polizzotti; Balakrishnan Ganapathy; Stuart Walsh; Sangita Choudhury; Niyatie Ammanamanchi; David G Bennett; Cristobal G dos Remedios; Bernhard J Haubner; Josef M Penninger; Bernhard Kühn
Journal:  Sci Transl Med       Date:  2015-04-01       Impact factor: 17.956

Review 3.  Treatment of pulmonary arterial hypertension in children.

Authors:  Heiner Latus; Tammo Delhaas; Dietmar Schranz; Christian Apitz
Journal:  Nat Rev Cardiol       Date:  2015-02-03       Impact factor: 32.419

4.  Cardiac T1 mapping in congenital heart disease: bolus vs. infusion protocols for measurements of myocardial extracellular volume fraction.

Authors:  Nadya Al-Wakeel-Marquard; Sanaz Rastin; Frédéric Muench; Darach O H-Ici; Sevim Yilmaz; Felix Berger; Titus Kuehne; Daniel R Messroghli
Journal:  Int J Cardiovasc Imaging       Date:  2017-06-15       Impact factor: 2.357

5.  Fibrosis and Fibrotic Gene Expression in Pediatric and Adult Patients With Idiopathic Dilated Cardiomyopathy.

Authors:  Kathleen C Woulfe; Austine K Siomos; Hieu Nguyen; Megan SooHoo; Csaba Galambos; Brian L Stauffer; Carmen Sucharov; Shelley Miyamoto
Journal:  J Card Fail       Date:  2016-11-24       Impact factor: 5.712

6.  Mapping versus source methods for quantifying myocardial T1 in controls and in repaired tetralogy of Fallot: interchangeability and reproducibility in children.

Authors:  Christopher Z Lam; Joseph J Pagano; Deane Yim; Shi-Joon Yoo; Mike Seed; Lars Grosse-Wortmann
Journal:  Pediatr Radiol       Date:  2019-06-12

7.  A cryoinjury model in neonatal mice for cardiac translational and regeneration research.

Authors:  Brian D Polizzotti; Balakrishnan Ganapathy; Bernhard J Haubner; Josef M Penninger; Bernhard Kühn
Journal:  Nat Protoc       Date:  2016-02-18       Impact factor: 13.491

8.  Creation of a restrictive atrial communication in heart failure with preserved and mid-range ejection fraction: effective palliation of left atrial hypertension and pulmonary congestion.

Authors:  Anna Bauer; Markus Khalil; Monika Lüdemann; Jürgen Bauer; Anoosh Esmaeili; Roberta De-Rosa; Norbert F Voelkel; Hakan Akintuerk; Dietmar Schranz
Journal:  Clin Res Cardiol       Date:  2018-04-16       Impact factor: 5.460

9.  Control of cytokinesis by β-adrenergic receptors indicates an approach for regulating cardiomyocyte endowment.

Authors:  Honghai Liu; Cheng-Hai Zhang; Niyatie Ammanamanchi; Sangita Suresh; Christopher Lewarchik; Krithika Rao; Gerrida M Uys; Lu Han; Maryline Abrial; Dean Yimlamai; Balakrishnan Ganapathy; Christelle Guillermier; Nathalie Chen; Mugdha Khaladkar; Jennifer Spaethling; James H Eberwine; Junhyong Kim; Stuart Walsh; Sangita Choudhury; Kathryn Little; Kimberly Francis; Mahesh Sharma; Melita Viegas; Abha Bais; Dennis Kostka; Jun Ding; Ziv Bar-Joseph; Yijen Wu; Vijay Yechoor; Mousumi Moulik; Jennifer Johnson; Jacqueline Weinberg; Miguel Reyes-Múgica; Matthew L Steinhauser; Bernhard Kühn
Journal:  Sci Transl Med       Date:  2019-10-09       Impact factor: 17.956

10.  Design and rationale of a clinical trial to increase cardiomyocyte division in infants with tetralogy of Fallot.

Authors:  Samar R El Khoudary; Anthony Fabio; Jessie W Yester; Matthew L Steinhauser; Adam B Christopher; Frank Gyngard; Phillip S Adams; Victor O Morell; Melita Viegas; Jose P Da Silva; Luciana F Da Silva; Mario Castro-Medina; Andrew McCormick; Miguel Reyes-Múgica; Michelle Barlas; Honghai Liu; Dawn Thomas; Niyatie Ammanamanchi; Rachel Sada; Megan Cuda; Elizabeth Hartigan; David K Groscost; Bernhard Kühn
Journal:  Int J Cardiol       Date:  2021-07-12       Impact factor: 4.164
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.